Results 141 to 150 of about 17,864 (222)

Carbapenem-hydrolyzing Oxacillinase-48 and Oxacillinase-181 in Canada, 2011

Emerging Infectious Diseases, 2013
Laura F. Mataseje, David A. Boyd, Linda Hoang, Miguel Imperial, Brigitte Lefebvre, Mark Miller, Susan M. Poutanen, Diane Roscoe, Barbara M. Willey, Michael R. Mulvey   +9 more
doaj   +1 more source

From Susceptible to Resistant: The Emergence of Carbapenemase-Producing Escherichia coli. [PDF]

Cureus
Kadam AC, Patil HV, Patil SR.
europepmc   +1 more source

Diagnostic Performance of Combination Disk and CIM Tests for Carbapenemase Detection in Enterobacterales Compared with Real-Time Multiplex PCR. [PDF]

Infect Dis Clin Microbiol
Çabuk A, Bakıcı MZ, Çelik C, Çalı A, Akbulut RE.   +4 more
europepmc   +1 more source

A Review of <i>β</i>-Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications. [PDF]

Int J Microbiol
Gourabi MJR, Nikoo A, Khanbabaei B, Kargar M, Fayyazi A, Mousavi SMJ, Aghdaee A, Hashemi A, Sharahi JY.   +8 more
europepmc   +1 more source

Spread of carbapenemase-producing <i>Serratia</i> spp. in France from 2016 to 2024: a comparative genomic study. [PDF]

Emerg Microbes Infect
Rezzoug I, Bernabeu S, Ouacel K, Birer A, Jousset AB, Larouy-Maumus G, Bonnin RA, Emeraud C, Dortet L.   +8 more
europepmc   +1 more source

Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Zagreb, Croatia, in Post-COVID-19 Pandemic Period: Resistance Trends and Mechanisms. [PDF]

Microorganisms
Bedenić B, Nađ M, Bratić V, Pavlović DB, Kasalo M, Dobrić M, Pino RAD, Burgwinkel T, Grisold A, Luxner J, Zarfel G, Higgins PG.   +11 more
europepmc   +1 more source

Genomic and Phenotypic Insights into Carbapenemase-Mediated Resistance and Clonal Diversity of Pseudomonas aeruginosa Clinical Isolates from Southern Brazil. [PDF]

Curr Microbiol
Bejes BM, Vicari MR, Nogaroto V, Bail L, Arend LNVS, da Silva Nogueira K, Pileggi SAV, Tuon FF, Ito CAS, Olchanheski LR, Pileggi M.   +10 more
europepmc   +1 more source

Restoration of Mucosa-Associated Invariant T-Cell Function in Healthcare-Associated Bacterial Infections Supports Recovery of Carbapenem Efficacy Against Resistant Bacteria Ex Vivo. [PDF]

J Infect Dis
Xue Y, Karim AM, Sia WR, Han F, Chan KL, Chua NG, Hadadi L, Liu Z, Mak JYW, Fairlie DP, Wang LF, Sandberg JK, Kwa AL, Leeansyah E.   +13 more
europepmc   +1 more source

Detection of carbapenemase activity using VITEK MS: interplay of carbapenemase type and period of incubation

Journal of Medical Microbiology, 2015
Cecilia Godoy, Carvalhaes, Ana Carolina Ramos, da Silva, Ana Paula, Streling, Rodrigo, Cayô, Anna Carolina, Rockstroh, Antonia Maria Oliveira, Machado, Ana Cristina, Gales   +6 more
openaire   +2 more sources